Iovance Biotherapeutics, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.15M-0.44M0.01M1.19M164.07M
Cost of Revenue 10.76M124.00M
Gross Profit -0.15M-0.44M0.01M-9.57M40.08M
Operating items
Amortization - Intangibles 5.00M
Research & Development 0.17M1.76M2.15M3.85M15.47M26.94M71.61M99.83M259.04M294.78M344.08M282.34M
Selling, General & Administrative 3.83M8.19M12.39M26.70M21.26M28.43M83.66M104.10M106.92M153.02M
Other Operating Expenses 0.02M0.64M19.46M16.66M10.76M124.00M
Operating Expenses 0.02M0.82M21.22M22.64M12.04M27.86M53.64M92.88M128.26M342.70M398.88M461.75M559.35M
Operating Income -0.02M-0.82M-21.22M-22.64M-12.04M-27.86M-53.64M-92.88M-128.26M-342.70M-398.88M-460.56M-395.28M
EBIT -0.02M-0.82M-21.22M-22.64M-12.04M-27.86M-53.64M-92.88M-128.26M-342.70M-398.88M-460.56M-395.28M
Non-operating items
Interest & Investment Income 0.01M0.20M0.74M0.81M4.68M0.45M2.98M13.04M20.27M
Other Non Operating Income -0.79M-4.48M-2.74M0.01M0.20M
Non Operating Income -0.79M-4.48M-2.74M0.01M0.20M
Net income details
EBT -0.02M-0.82M-21.37M-23.09M-12.03M-27.66M-52.89M-92.06M-123.58M-342.25M-395.89M-447.52M-375.00M
Tax Provisions -3.50M-2.83M
Profit After Tax -0.02M-1.61M-25.69M-25.38M-12.04M-27.66M-52.89M-92.06M-123.58M-342.25M-395.89M-444.04M-372.20M
Income from Continuing Operations -0.02M-0.82M-21.37M-23.09M-12.03M-27.66M-52.89M-92.06M-123.58M-342.25M-395.89M-444.02M-372.18M
Consolidated Net Income -0.02M-0.82M-21.37M-23.09M-12.03M-27.66M-52.89M-92.06M-123.58M-342.25M-395.89M-444.02M-372.18M
Income towards Parent Company -0.02M-0.82M-21.37M-23.09M-12.03M-27.66M-52.89M-92.06M-123.58M-342.25M-395.89M-444.02M-372.18M
Preferred Dividend Payments 8.46M49.45M
Net Income towards Common Stockholders -0.02M-0.82M-21.37M-33.84M-12.04M-27.66M-102.35M-92.06M-123.58M-342.25M-395.89M-444.02M-372.18M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.05M0.73M0.79M18.89M27.64M47.83M62.09M72.63M123.17M126.19M146.69M156.90M157.84M255.92M304.78M
Shares Outstanding (Diluted Average) 0.24M0.29M
EBITDA -0.02M-0.82M-21.22M-22.64M-12.04M-27.86M-53.64M-92.88M-128.26M-342.70M-398.88M-460.56M-395.28M
Tax Rate 0.78%0.75%